المؤلفون: Martinón-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, University of Santiago, La Coruña, Spain., Rusch S; Quantitative Sciences, Janssen Research and Development, Beerse, Belgium., Huntjens D; Quantitative Sciences, Janssen Research and Development, Beerse, Belgium., Remmerie B; Quantitative Sciences, Janssen Research and Development, Beerse, Belgium., Vingerhoets J; Clinical Virology, Janssen Research and Development, Beerse, Belgium., McFadyen K; Global Clinical Development Operations Infectious Diseases, Janssen Research and Development, Washington, District of Columbia, USA., Ferrero F; Hospital General de Niños 'Pedro de Elizalde,' Buenos Aires, Argentina., Baraldi E; Women's and Children's Health Department, University Hospital of Padova, Padova, Italy., Rojo P; Pediatric Infectious Disease Unit, Hospital Universitario 12 de Octubre, Universidad Complutense, Instituto de Investigación Hospital 12 de Octubre, Translational Research Network in Pediatric Infectology, Madrid, Spain., Epalza C; Pediatric Infectious Disease Unit, Hospital Universitario 12 de Octubre, Universidad Complutense, Instituto de Investigación Hospital 12 de Octubre, Translational Research Network in Pediatric Infectology, Madrid, Spain., Stevens M; Global Clinical Development Infectious Diseases, Janssen Research and Development, Beerse, Belgium.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Dec 17; Vol. 71 (10), pp. e594-e603.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Imidazolidines*/therapeutic use , Respiratory Syncytial Virus Infections*/drug therapy, Aged ; Antiviral Agents/therapeutic use ; Double-Blind Method ; Humans ; Indoles/therapeutic use ; Infant

المؤلفون: Steiner-Monard V; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Kamaka K; Ifakara Health Institute, Bagamoyo, Tanzania., Karoui O; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Roethlisberger S; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Audran R; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Daubenberger C; Swiss Tropical and Public Health Institute, Basel., Fayet-Mello A; Clinical Trial Unit, CHUV, Lausanne., Erdmann-Voisin A; Clinical Trial Unit, CHUV, Lausanne., Felger I; Swiss Tropical and Public Health Institute, Basel., Geiger K; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Govender L; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Houard S; European Vaccine Initiative, Heidelberg, Germany., Huber E; Swiss Tropical and Public Health Institute, Basel., Mayor C; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Mkindi C; Swiss Tropical and Public Health Institute, Basel., Portevin D; Swiss Tropical and Public Health Institute, Basel., Rusch S; Swiss Tropical and Public Health Institute, Basel., Schmidlin S; Swiss Tropical and Public Health Institute, Basel., Tiendrebeogo RW; Department for Congenital Disorders, Statens Serum Institut, Denmark.; Centre for Medical Parasitology, University of Copenhagen, Denmark.; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark., Theisen M; Department for Congenital Disorders, Statens Serum Institut, Denmark.; Centre for Medical Parasitology, University of Copenhagen, Denmark.; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark., Thierry AC; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Vallotton L; Clinical Trial Unit, CHUV, Lausanne., Corradin G; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Leroy O; European Vaccine Initiative, Heidelberg, Germany., Abdulla S; Ifakara Health Institute, Bagamoyo, Tanzania., Shekalaghe S; Ifakara Health Institute, Bagamoyo, Tanzania., Genton B; Swiss Tropical and Public Health Institute, Basel.; Policlinique médicale universitaire, Lausanne, Switzerland.; Infectious Disease Service, CHUV, Lausanne, Switzerland., Spertini F; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Jongo SA; Ifakara Health Institute, Bagamoyo, Tanzania.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Jan 18; Vol. 68 (3), pp. 466-474.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Protozoan/*blood , Malaria Vaccines/*immunology , Malaria, Falciparum/*prevention & control, Adjuvants, Immunologic/administration & dosage ; Adolescent ; Adult ; Aluminum Hydroxide/administration & dosage ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; Glucosides/administration & dosage ; Healthy Volunteers ; Humans ; Injections, Intramuscular ; Lipid A/administration & dosage ; Malaria Vaccines/administration & dosage ; Malaria Vaccines/adverse effects ; Male ; Middle Aged ; Plasmodium falciparum ; Switzerland ; Tanzania ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/immunology ; Young Adult

المؤلفون: Theilacker C; Center for Chronic Immunodeficiency.; Division of Infectious Diseases, Department of Medicine., Ludewig K; Center for Sepsis Control and Care., Serr A; Institute for Microbiology and Hygiene., Schimpf J; Institute for Microbiology and Hygiene., Held J; Institute for Microbiology and Hygiene.; Mikrobiologisches Institut, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität Erlangen-Nürnberg., Bögelein M; Center for Chronic Immunodeficiency.; Division of Infectious Diseases, Department of Medicine.; Clinical Research Unit, Freiburg University Medical Center., Bahr V; Center for Sepsis Control and Care., Rusch S; Clinical Research Unit,Freiburg University Medical Center., Pohl A; Center for Chronic Immunodeficiency.; Clinical Research Unit, Freiburg University Medical Center., Kogelmann K; Klinikum Emden., Frieseke S; Klinikum Emden., Bogdanski R; Klinikum rechts der Isar, Technical University, Munich, Germany., Brunkhorst FM; Center for Sepsis Control and Care.; Paul Martini Sepsis Research Group, Jena University Hospital., Kern WV; Division of Infectious Diseases, Department of Medicine.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2016 Apr 01; Vol. 62 (7), pp. 871-878. Date of Electronic Publication: 2015 Dec 23.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Pneumococcal Infections/*epidemiology , Postoperative Complications/*epidemiology , Sepsis/*epidemiology , Splenectomy/*adverse effects, Adult ; Aged ; Female ; Humans ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Pneumococcal Infections/etiology ; Pneumococcal Infections/microbiology ; Pneumococcal Infections/mortality ; Pneumococcal Vaccines ; Postoperative Complications/etiology ; Postoperative Complications/microbiology ; Postoperative Complications/mortality ; Prospective Studies ; Risk Factors ; Sepsis/etiology ; Sepsis/microbiology ; Sepsis/mortality ; Streptococcus pneumoniae ; Vaccination/statistics & numerical data